Understanding Transcutaneous Auricular Neurostimulation for Chronic Pain
This study is looking at how a device called transcutaneous auricular neurostimulation (tAN), worn on the ear, might help people with chronic pain who are reducing their opioid medication. The device works by stimulating nerves around the ear, which is thought to change signals in the brain. Researchers want to see if this device can reduce pain and withdrawal symptoms. You would be asked to reduce your pain medication and then spend several days and nights at the Clinical Research Center at UTMB in Galveston. During this time, you would receive either active tAN stimulation or a sham (inactive) stimulation, and researchers would monitor your withdrawal symptoms. The study aims to enroll 60 participants aged 18 to 65 who have experienced pain for more than six months and have a prescription for pain medication.
- Study design
- This is an interventional study comparing active transcutaneous auricular neurostimulation (tAN) to sham tAN. It plans to enroll 60 participants.
- What's involved
- You would be asked to reduce your pain medication and then spend several days and nights at the Clinical Research Center at UTMB in Galveston. Withdrawal symptoms would be monitored, and you would receive either active or sham stimulation.
- Compensation
- Not stated in the trial record.
- Follow-up
- Withdrawal symptoms will be measured on day 1 and day 4.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Clinical opioid withdrawal scale (COWS)day 1 and day 4
Examination and scoring of symptoms of opioid withdrawal. score range is 1-36 with 1-2 mild, 3-24 moderate, and 25-36 severe withdrawal symptoms measured pre-treatment (day 1) and post-treatment (day4